Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS)
IBS
Exploratory Randomised Controlled Trial of a Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS) in a Low-income Country
1 other identifier
interventional
45
1 country
1
Brief Summary
Irritable bowel syndrome (IBS) is a highly prevalent functional bowel disorder routinely encountered by healthcare providers although it's not life-threatening, this chronic disorder has ability to reduce patients' quality of life and imposes a significant economic burden to the healthcare system.Despite the high prevalence of IBS and its association with disability and adverse effect on health related quality of life we are not aware of any published trial of psychological intervention for IBS from Pakistan. We aim to test the feasibility and acceptability of culturally adapted Cognitive Behaviour Therapy (CBT) for the management of IBS in Karachi, Pakistan compared to treatment as usual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2017
CompletedFirst Posted
Study publicly available on registry
December 20, 2017
CompletedStudy Start
First participant enrolled
December 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2019
CompletedNovember 14, 2022
November 1, 2022
10 months
October 26, 2017
November 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IBS-symptom severity scale
The score of this system is based on five items (severity and duration of pain, abdominal distension, bowel satisfaction, and interference with life in general) and uses visual analogue scales. Patients can be categorized as having mild (75-175), moderate (175-300), or severe (\>300) IBS.
Change to baseline at 3rd Month
Secondary Outcomes (11)
IBS Rome III
Baseline
IBS quality of Life III
Baseline & 3rd Month
IBS pain scale-Pain Vigilance and Awareness Questionnaire
Baseline & 3rd Month
Brief Disability Questionnaire (BDQ)
Baseline & 3rd Month
Client Satisfaction Questionnaire
3rd month
- +6 more secondary outcomes
Study Arms (2)
culturally adapted Cognitive Behavior Therapy
EXPERIMENTALWe will use The STreSS CBT manual developed by Schroder and his colleagues
Treatment As Usual
NO INTERVENTIONThe Treatment As Usual (TAU) group will receive regular treatment they have been receiving already as prescribed by the physician.
Interventions
Culturally adapted Cognitive Behavior Therapy for IBS
Eligibility Criteria
You may qualify if:
- Individuals with ROME 111 diagnoses of IBS
- Between the age bracket of 18 to 55 years.
- willing to give written informed consent.
You may not qualify if:
- Individuals with atypical symptoms (rectal bleeding, anaemia or unexplained weightloss).
- Diagnosis of inflammatory bowel disease, celiac disease or colon cancer.
- Pregnant or breast feeding.
- History of drug, alcohol, or chemical abuse within 6 months prior to screening.
- Metabolic dysfunction, serious physical examination finding, or clinical laboratory finding giving reasonable suspicion that it might affect the interpretation of the re-sults or render the patient at high risk from treatment complication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abasi Shaheed Hospital
Karachi, Sindh, 72000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof. Nusrat Husain
University of Manchester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2017
First Posted
December 20, 2017
Study Start
December 30, 2017
Primary Completion
October 20, 2018
Study Completion
May 30, 2019
Last Updated
November 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share